Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation

Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.

NCT04178057 ·Status: UNKNOWN ·Phase: PHASE1

Niraparib Combined With Radiotherapy in rGBM

NCT04715620 ·Status: UNKNOWN ·Phase: PHASE2

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

NCT04915404 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Response-based Treatment of High-risk Neuroblastoma

NCT02771743 ·Status: UNKNOWN ·Phase: PHASE2

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

NCT05773326 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

NCT04762069 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

NCT06737146 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

NCT06072586 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

NCT00671710 ·Status: COMPLETED ·Phase: PHASE1

A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma

NCT04458272 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

NCT06773481 ·Status: RECRUITING ·Phase: PHASE1

A Phase 0 Study of AZD1775 in Recurrent GBM Patients

NCT02207010 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

NCT00052013 ·Status: COMPLETED ·Phase: PHASE2

Sequence of Radiation and Targeted Therapy in Brain Metastases

NCT04832672 ·Status: COMPLETED

A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma

NCT05324501 ·Status: TERMINATED ·Phase: PHASE1

Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation

NCT06780930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

NCT07268053 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

NCT02684058 ·Status: COMPLETED ·Phase: PHASE2

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

NCT00562419 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

NCT05226494 ·Status: RECRUITING ·Phase: PHASE1

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

NCT01517776 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

NCT02333513 ·Status: UNKNOWN ·Phase: NA

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

NCT04178330 ·Status: COMPLETED ·Phase: NA

A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain

NCT01563614 ·Status: TERMINATED ·Phase: PHASE1

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

NCT01878617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2